Genevant Sciences is a technology-focused nucleic acid development and delivery company with a proprietary LNP platform. Headquartered in Vancouver, Canada, the company has over 20 years of experience in lipid nanoparticle composition, formulation, and manufacture. Some of the company’s innovations include biodegradable lipids, lyophilized drug products, and access to cells and tissues outside the liver. Genevant selectively collaborates with leading pharma and biotech companies developing innovative advanced therapy medicinal products (ATMPs), including mRNA-based vaccines and therapeutics.